Loyal, a company developing treatments for longevity in dogs, recently announced that they have "completed the technical effectiveness portion of their conditional approval for [their first drug candidate]".
Will they successfully establish safety of LOY-001 (according to the FDA)? Resolves NO if they fail for any reason, including, for example, running out of money before they complete their studies.
Get Ṁ600 play money
Related questions
Will the US government require AI labs to run safety/alignment evals by 2025?
39% chance
Is RLHF good for AI safety? [resolves to poll]
45% chance
Will LOY-001 establish efficacy?
17% chance
Conditional on any room-temp superconductor being replicated before 2025, will the main LK-99 market resolve YES?
33% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
Will AOH1996 succeed in Phase I trial?
81% chance
Will at least 15 top-100 universities have a faculty-led technical AGI safety effort by the end of 2024?
44% chance
Will at least 25 top-100 universities have a faculty-led technical AGI safety effort by the end of 2024?
28% chance
Will I still consider improving AI X-Safety my top priority on EOY 2024?
61% chance
Conditional on safe AGI being developed, will there be significant mathematical results proving its safety properties?
24% chance